{"id":30984,"date":"2022-06-07T23:16:00","date_gmt":"2022-06-07T23:16:00","guid":{"rendered":"\/p\/a-drug-trial-with-18-rectal-cancer-patients-ended-with-the-cancer-vanishing#id31946"},"modified":"2022-06-07T23:16:00","modified_gmt":"2022-06-07T23:16:00","slug":"in-a-stunning-result-a-drug-trial-with-18-rectal-cancer-patients-ended-with-the-cancer-vanishing-in-every-single-one-of-them","status":"publish","type":"post","link":"https:\/\/associatednews.us\/content\/in-a-stunning-result-a-drug-trial-with-18-rectal-cancer-patients-ended-with-the-cancer-vanishing-in-every-single-one-of-them\/","title":{"rendered":"In a stunning result, a drug trial with 18 rectal-cancer patients ended with the cancer vanishing in every single one of them."},"content":{"rendered":"<figure><figcaption>\n<p>          In a stunning result, a drug trial with 18 rectal-cancer patients ended with the cancer vanishing in every single one of them.<\/p>\n<\/figcaption><\/figure>\n<p><a href=\"https:\/\/www.nytimes.com\/2022\/06\/05\/health\/rectal-cancer-checkpoint-inhibitor.html\">&#x021A9;&#xFE0E; The New York Times<\/a><\/p>\n<p><a href=\"https:\/\/themorningnews.org\/p\/a-drug-trial-with-18-rectal-cancer-patients-ended-with-the-cancer-vanishing\">View Post &rarr;<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>          In a stunning result, a drug trial with 18 rectal-cancer patients ended with the cancer vanishing in every single one of them.<\/p>\n<p>    &#x21A9;&#xFE0E; The New York Times<br \/>\n &#8230;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-30984","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/associatednews.us\/content\/wp-json\/wp\/v2\/posts\/30984","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/associatednews.us\/content\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/associatednews.us\/content\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/associatednews.us\/content\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/associatednews.us\/content\/wp-json\/wp\/v2\/comments?post=30984"}],"version-history":[{"count":1,"href":"https:\/\/associatednews.us\/content\/wp-json\/wp\/v2\/posts\/30984\/revisions"}],"predecessor-version":[{"id":30985,"href":"https:\/\/associatednews.us\/content\/wp-json\/wp\/v2\/posts\/30984\/revisions\/30985"}],"wp:attachment":[{"href":"https:\/\/associatednews.us\/content\/wp-json\/wp\/v2\/media?parent=30984"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/associatednews.us\/content\/wp-json\/wp\/v2\/categories?post=30984"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/associatednews.us\/content\/wp-json\/wp\/v2\/tags?post=30984"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}